Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
129,821,091
-
Total 13F shares
-
40,601
-
Share change
-
-25,423
-
Total reported value
-
$72,270
-
Price per share
-
$1.78
-
Number of holders
-
2
-
Value change
-
-$45,253
-
Number of sells
-
1
Institutional Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q4 2023
As of 31 Dec 2023,
PROKIDNEY CORP. - Ordinary Shares (PROK) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,601 shares.
The largest 10 holders included
MORGAN STANLEY, SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Inc., Bleichroeder LP, Brown University, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, and MILLENNIUM MANAGEMENT LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.